X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
50
PharmaCompass offers a list of Budesonide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Budesonide manufacturer or Budesonide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Budesonide manufacturer or Budesonide supplier.
PharmaCompass also assists you with knowing the Budesonide API Price utilized in the formulation of products. Budesonide API Price is not always fixed or binding as the Budesonide Price is obtained through a variety of data sources. The Budesonide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Budesonide 21-acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Budesonide 21-acetate, including repackagers and relabelers. The FDA regulates Budesonide 21-acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Budesonide 21-acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Budesonide 21-acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Budesonide 21-acetate supplier is an individual or a company that provides Budesonide 21-acetate active pharmaceutical ingredient (API) or Budesonide 21-acetate finished formulations upon request. The Budesonide 21-acetate suppliers may include Budesonide 21-acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Budesonide 21-acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Budesonide 21-acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Budesonide 21-acetate active pharmaceutical ingredient (API) in detail. Different forms of Budesonide 21-acetate DMFs exist exist since differing nations have different regulations, such as Budesonide 21-acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Budesonide 21-acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Budesonide 21-acetate USDMF includes data on Budesonide 21-acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Budesonide 21-acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Budesonide 21-acetate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Budesonide 21-acetate Drug Master File in Japan (Budesonide 21-acetate JDMF) empowers Budesonide 21-acetate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Budesonide 21-acetate JDMF during the approval evaluation for pharmaceutical products. At the time of Budesonide 21-acetate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Budesonide 21-acetate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Budesonide 21-acetate Drug Master File in Korea (Budesonide 21-acetate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Budesonide 21-acetate. The MFDS reviews the Budesonide 21-acetate KDMF as part of the drug registration process and uses the information provided in the Budesonide 21-acetate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Budesonide 21-acetate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Budesonide 21-acetate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Budesonide 21-acetate suppliers with KDMF on PharmaCompass.
A Budesonide 21-acetate CEP of the European Pharmacopoeia monograph is often referred to as a Budesonide 21-acetate Certificate of Suitability (COS). The purpose of a Budesonide 21-acetate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Budesonide 21-acetate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Budesonide 21-acetate to their clients by showing that a Budesonide 21-acetate CEP has been issued for it. The manufacturer submits a Budesonide 21-acetate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Budesonide 21-acetate CEP holder for the record. Additionally, the data presented in the Budesonide 21-acetate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Budesonide 21-acetate DMF.
A Budesonide 21-acetate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Budesonide 21-acetate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Budesonide 21-acetate suppliers with CEP (COS) on PharmaCompass.
A Budesonide 21-acetate written confirmation (Budesonide 21-acetate WC) is an official document issued by a regulatory agency to a Budesonide 21-acetate manufacturer, verifying that the manufacturing facility of a Budesonide 21-acetate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Budesonide 21-acetate APIs or Budesonide 21-acetate finished pharmaceutical products to another nation, regulatory agencies frequently require a Budesonide 21-acetate WC (written confirmation) as part of the regulatory process.
click here to find a list of Budesonide 21-acetate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Budesonide 21-acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Budesonide 21-acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Budesonide 21-acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Budesonide 21-acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Budesonide 21-acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Budesonide 21-acetate suppliers with NDC on PharmaCompass.
Budesonide 21-acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Budesonide 21-acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Budesonide 21-acetate GMP manufacturer or Budesonide 21-acetate GMP API supplier for your needs.
A Budesonide 21-acetate CoA (Certificate of Analysis) is a formal document that attests to Budesonide 21-acetate's compliance with Budesonide 21-acetate specifications and serves as a tool for batch-level quality control.
Budesonide 21-acetate CoA mostly includes findings from lab analyses of a specific batch. For each Budesonide 21-acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Budesonide 21-acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Budesonide 21-acetate EP), Budesonide 21-acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Budesonide 21-acetate USP).
Market Place
